QUANTUM X LABS INC.
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 13, 2026
QXL$3.31-2.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Interim Condensed Consolidated Statements of Cash Flows (unaudited)
| For the six months ended June 30, | For the three months ended June 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Cash flows from Operating Activities of Continuing Operations | ||||
| Net income (loss) | 1,812 | (16,262) | 2,417 | (12,418) |
| Less: net loss from discontinued operations | - | 4,681 | - | 3,801 |
| Net income (loss) from continuing operations | 1,812 | (11,581) | 2,417 | (8,617) |
| Adjustments to reconcile net loss from continuing operations to net cash provided by operating activities: | ||||
| Depreciation and amortization | 452 | 408 | 228 | 235 |
| Share-based compensation | - | 75 | - | 75 |
| Deferred taxes | (55) | (32) | (27) | (24) |
| Accrued interest, net | 41 | (15) | 16 | 4 |
| Interest income | - | (63) | - | (25) |
| Amortization of loan discounts | - | 38 | - | 16 |
| Change in the fair value of financial assets at fair value through profit or loss (see note 8) | - | 10,121 | - | 7,398 |
| Amortization of deferred debt issuance costs (see notes 7.D. 7.E, 7.F) | 6 | 134 | 2 | 66 |
| Gain arising from deconsolidation of a subsidiary upon loss of control (see note 6.D) | (3,831) | - | (3,831) | - |
| Changes in assets and liabilities items: | ||||
| Decrease in accounts receivable | 34 | 206 | 74 | 85 |
| Increase in other current assets | (60) | (106) | (24) | (53) |
| Increase in related parties | 89 | - | 89 | - |
| Increase (decrease) in accounts payable | (133) | 403 | 61 | 514 |
| Decrease (increase) in other payables | (21) | 123 | (67) | (154) |
| Net cash used in operating activities from continuing operations | (1,666) | (289) | (1,062) | (480) |
-9-
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (Cont.)
| For the six months ended June 30, | For the three months ended June 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Cash flows from Investing Activities of Continuing Operations | ||||
| Purchase of property and equipment | (186) | - | (186) | - |
| Deconsolidation of a subsidiary upon loss of control (see appendix B and note 6.D) | (120) | - | (120) | - |
| Net cash from acquisition of subsidiaries (see appendix A and notes 6.B, 6.C) | 193 | 12 | - | - |
| Net cash provided by (used in) investing activities from continuing operations | (113) | 12 | (306) | - |
| Cash flows from Financing Activities of Continuing Operations | ||||
| Receipt of short-term convertible loans | - | 630 | - | 630 |
| Repayment of short-term convertible loans | (200) | - | (200) | - |
| Receipt of short-term bank loans | 2 | 4,277 | - | 2,248 |
| Repayment of short-term bank loans | - | (3,263) | (5) | (1,698) |
| Repayment of long-term bank loans | (391) | (1,327) | (195) | (669) |
| Change in loan to former parent company | - | (4) | - | (10) |
| Proceeds from issuance of shares and warrants in connection with the 2026 Private Placement (see note 10.D) | 1,400 | - | - | - |
| Proceeds from exercise of warrants | 2,413 | 1,820 | 2,413 | 1,820 |
| Net cash provided by financing activities from continuing operations | 3,224 | 2,133 | 2,013 | 2,321 |
| Cash flows of Discontinued Operations | ||||
| Net cash used in operating activities from discontinued operations | - | (547) | - | 53 |
| Net cash used in investing activities from discontinued operations | - | - | - | - |
| Net cash provided by financing activities from discontinued operations | - | 170 | - | 27 |
| Net cash used in discontinued operations | - | (377) | - | 80 |
| Increase in cash and cash equivalents and restricted cash | 1,445 | 1,479 | 645 | 1,921 |
| Cash and cash equivalents and restricted cash at beginning of period | 1,038 | 682 | 1,838 | 240 |
| Cash and cash equivalents and restricted cash at end of period | 2,483 | 2,161 | 2,483 | 2,161 |
| Supplemental Disclosure of Cash Flow Activities: | ||||
| Cash paid during the period | ||||
| Taxes paid | 12 | 5 | 10 | 4 |
| Interest paid | 63 | 265 | 29 | 124 |
| Total cash paid during the period | 75 | 270 | 39 | 128 |
| Substantial non-cash activities: | ||||
| Redeem of loan to parent company | - | 4,048 | - | 4,048 |
| Conversion of loans into shares and warrants | - | 922 | - | 922 |
| Issuance of warrants in connection with the 2026 Private Placement (see note 10.D) | 34 | - | - | - |
| Classification of Earn-out liability to Earn-out payable (see note 8) | 67 | - | - | - |
-10-
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (Cont.)
Appendix A:
| Consolidation of Quantum Israel (see note 6.C): | |
|---|---|
| Net working capital other than cash and restricted deposits | 211 |
| Property and equipment | 9 |
| Goodwill | 14,329 |
| In-process research and development, net of deferred taxes | 508 |
| Non-controlling interests | (79) |
| Total consideration | (15,171) |
| Net cash acquired | (193) |
Appendix B:
| Deconsolidation of subsidiary upon loss of control (see note 6.D): | |
|---|---|
| Net working capital other than cash and restricted deposits | 100 |
| Recognition of investment accounted for using the equity method | 3,840 |
| Non-controlling interests | 11 |
| Gain arising from deconsolidation upon loss of control | (3,831) |
| Net cash deconsolidated upon loss of control | 120 |
-11-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.